Related Experiment Video
Updated: Mar 14, 2026
10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
10.4K
Definitive LC-MS/MS Drug Monitoring Impacts Substance-use Treatment Planning and Patient Outcomes: A Brief Report
Adam Rzetelny1, Barbara Zeller, Nicholas Miller
1Millennium Health (AR, NM, KLK, SDP), San Diego, CA; and HELP/Project Samaritan Inc (HELP/PSI) (BZ), New York, NY.
Journal of Addiction Medicine
|September 21, 2016
Summary
Definitive drug testing, using liquid chromatography with tandem mass spectrometry, improved treatment planning for substance use disorders. This advanced monitoring identified relapses and led to significant treatment adjustments, enhancing patient outcomes and reducing illicit drug use.
Area of Science:
- Clinical Chemistry
- Substance Use Disorder Treatment
- Analytical Toxicology
Background:
- Clinical drug monitoring is vital for substance use disorder (SUD) treatment.
- Previous drug testing methods were less sensitive, potentially missing patient relapses.
Purpose of the Study:
- To assess the clinical impact of switching to definitive drug testing (liquid chromatography with tandem mass spectrometry) on SUD patient treatment.
- To understand how enhanced drug monitoring influences treatment planning and patient outcomes.
Main Methods:
- Semistructured interviews with 12 substance-use counselors.
- Counselors discussed the impact of definitive drug testing on 2 patients each.
- Study conducted during a facility-wide transition from immunoassay to liquid chromatography-tandem mass spectrometry testing.
Main Results:
- Definitive testing identified previously undetected substance use and relapses.
- 75% of discussed patients had treatment plan changes; 79% received enhanced education; 63% increased treatment intensity.
- 58% of patients reduced illicit and nonmedical prescription drug use.
- Improvements noted in therapeutic relationships and patient honesty.
Conclusions:
- Definitive drug monitoring provides crucial information for clinical decision-making in SUD treatment.
- Enhanced drug testing can lead to personalized treatment adjustments and improved patient outcomes.
- Results support the use of advanced drug testing methodologies to optimize SUD care.
Related Concept Videos
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
276
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
276
01:29Therapeutic Drug Monitoring: Affecting Factors
313
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
313
01:16Therapeutic Drug Monitoring: Overview and Classification
484
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
484
01:28Drug Therapy
364
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
364
01:23Drug Concentrations: Measurements
1.3K
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
1.3K
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
277
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
277